- Kindred Biosciences (KIN) announces positive results from its pilot field study of KIND-014 for the treatment of gastric ulcers in horses.
- This study was a placebo-controlled, dose-ranging study that enrolled 53 horses (40 horses in three groups with different doses and schedules, 13 in the placebo group). The objective was to determine the effective dose of KIND-014.
- At Week 3, the gastric ulcer resolution (gastric ulcer score=0) rates in all three KIND-014 groups were statistically higher than the placebo group (p-values < 0.05).